Furthermore, available data indicate that PD-1 upregulation on innate inflammatory cells may be a conserved response to ischemia, indicating potential therapeutic activity in myocardial infarction and other ischemic pathologies. This evidence concerns the gene PDCD1 and myocardial infarction.